Annual General Meeting 2021

The Annual General Meeting in Oncopeptides AB (publ) will be held on Wednesday May 26 in Stockholm, Sweden. In light of the coronavirus pandemic Oncopeptides AB (publ) will provide further information on the form of the Annual General Meeting.

Proposals:

Shareholders who wish to have a matter addressed by the Annual General Meeting can do so by sending an e-mail to lisa.andersson@oncopeptides.com (subject “Annual General Meeting”) or by letter posted to Oncopeptides AB (publ), Attn: General Counsel, Luntmakargatan 46, SE-111 37 Stockholm, Sweden

Shareholders who wishes to submit proposals to the Nomination Committee can do so by sending an e-mail to lisa.andersson@oncopeptides.com (subject “Nomination Committee”) or by letter posted to Oncopeptides AB (publ), Attn: Oncopeptides Nomination Committee, Luntmakargatan 46, SE-111 37 Stockholm, Sweden

Considering the scheduled date for publishing the Notice of the Annual General Meeting, proposals have to be received by the Company no later than April 12, 2021 and proposals to the Nomination Committee no later than Wednesday, April 7, 2021. This is in order to have sufficient time for including them in the Annual General Meeting Notice and Agenda, respectively.